Evidence map›Paper›PMID 31908923›Full record

ArticleMetabolic engineering communications2020

Improving heterologous protein expression in

Jacob Sebesta, Christie Am Peebles

Open access · goldAbstract read
In one paragraph

Article in Metabolic engineering communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Perspectives of cyanobacterial cell factories.Photosynthesis research · 2024
    Review
  8. Review
  9. The Molecular Toolset and Techniques Required to Build Cyanobacterial Cell Factories.Advances in biochemical engineering/biotechnology · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. FirstFrontiers in plant science · 2022
    Article
  14. Article
  15. Review
  16. Heterologous production of cyanobacterial compounds.Journal of industrial microbiology & biotechnology · 2021
    Review
  17. Metabolic engineering ofMetabolic engineering communications · 2021
    Article
  18. Review
  19. Diversifying Isoprenoid PlatformsFrontiers in microbiology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jacob SebestaDepartment of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, 80523, USA.
Christie Am PeeblesDepartment of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, 80523, USA.
Colorado State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanobacterial biofuels have the potential to reduce the cost and climate impacts of biofuel production because primary carbon fixation and conversion to fuel are completed together in the cultivation of the cyanobacteria. Cyanobacterial biofuels, therefore, do not rely on costly organic carbon feedstocks that heterotrophs require, which reduces competition for agricultural resources such as arable land and freshwater. However, the published product titer achieved for most molecules of interest using cyanobacteria lag behind what has been achieved using yeast and

Indexed as

BisaboleneMetabolic engineeringRibosome binding siteSynechocystis sp. PCC6803Synthetic biology

Identifiers

PMID31908923
PMCPMC6940699
OpenAlexW2995566875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.